All Pharma articles – Page 35
-
NewsPharma risk-sharing scheme a 'costly failure'
A risk-sharing agreement between the government and drug companies to supply expensive multiple sclerosis medicines was a “costly failure”, experts have claimed.
-
CommentMark Britnell on increasing NHS productivity
The new health secretary, Andrew Lansley, has already gone on public record to suggest that £15-20bn in efficiency savings may be needed.
-
NewsChild asthma drug 'too expensive'
An asthma drug for children will not be made available on the NHS after the regulator ruled that it was too expensive to justify.
-
HSJ KnowledgeManaging costs
Managing costs may seem like a daunting task, but adopting some simple measures will reap serious long-term rewards, says Debjani Duncan
-
NewsReform of NICE, value-based drug pricing and a 'cancer drugs fund' confirmed
The coaltion government has announced the National Institute for Health and Clinical Excellence will face “reform”.
-
News£100,000 fine over hospital death
A hospital trust has been ordered to pay £100,000 after a mother who had just given birth died due to a mix-up between “identical looking” drugs.
-
NewsNew drug approval guidance issued
Guidance on when new drugs should be used could benefit patients and their families in Scotland, health secretary Nicola Sturgeon has said.
-
NewsFree NHS prescriptions should be axed, say public sector chiefs
Free prescriptions and eye tests, along with other universal benefits, must be considered for the axe, public sector chiefs have said.
-
NewsElection 2010: a candidate watchlist for the NHS
The incoming and outgoing MPs that matter to the health service
-
NewsParties agree on need to tell patients about NHS service costs
All three main parties support ways of making the public more aware of the cost of NHS treatment and services, such as putting drug prices on prescriptions.
-
NewsTargeted treatments could reduce long term NHS costs
The NHS could make significant cost savings if it made better use of diagnostic tests and patient information to tailor treatment to individual patient groups, according to a report by international researchers.
-
NewsExperts issue cancer care election challenge
A group of cancer experts have challenged political parties to explain how they would cut waits for diagnosis and treatment of the disease, which they said offered the greatest hope of saving lives and improving life expectancy.
-
NewsDrug firms lose battle over pricing
A government scheme encouraging doctors to prescribe low-cost medicines has overcome a legal challenge by pharmaceutical companies.
-
NewsVolcanic ash cloud affects cancer drug supplies
The fallout from the volcanic eruption in Iceland has left cancer patients in the UK without life-extending drug treatment and vital stem cells for bone marrow transplants.
-
News'Trust' key to joint working between PCTs and pharma
Mutual trust and transparency is the key to successful joint working between primary care trusts and the pharmaceutical industry, according to a medical director who has worked for both sides.
-
NewsTrust announces board appointments
Colchester Hospital University foundation trust has announced the appointment of four non-executive directors (NEDs).
-
NewsLeaders clash over healthcare at general election debate
The leaders of the three main parties made history last night as they crossed swords in the first ever televised prime ministerial general election debate.
-
NewsVTE prevention help needed
A standard hospital drug chart should be introduced to help trusts meet demands to prevent venous thromboembolism, say the medical royal colleges.
-
NewsWhat Royal Surrey Foundation Trust sold
Names of products, dosages and units as described in a freedom of information release from Royal Surrey to Health Service Journal, April 2010.
-
NewsFT admits selling low-stock drugs
Drugs controversially sold onto the export market by Royal Surrey County Hospital Foundation Trust included cancer drugs now listed as in short supply to the NHS, HSJ can reveal.